Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1597

1.

Soil Salinity and pH Drive Soil Bacterial Community Composition and Diversity Along a Lateritic Slope in the Avon River Critical Zone Observatory, Western Australia.

O'Brien FJM, Almaraz M, Foster MA, Hill AF, Huber DP, King EK, Langford H, Lowe MA, Mickan BS, Miller VS, Moore OW, Mathes F, Gleeson D, Leopold M.

Front Microbiol. 2019 Jul 2;10:1486. doi: 10.3389/fmicb.2019.01486. eCollection 2019.

2.

Pan-Cancer Analysis of CDK12 Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype.

Sokol ES, Pavlick D, Frampton GM, Ross JS, Miller VA, Ali SM, Lotan TL, Pardoll DM, Chung JH, Antonarakis ES.

Oncologist. 2019 Jul 10. pii: theoncologist.2019-0214. doi: 10.1634/theoncologist.2019-0214. [Epub ahead of print]

PMID:
31292271
3.

FGFR2-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape.

Klempner SJ, Madison R, Pujara V, Ross JS, Miller VA, Ali SM, Schrock AB, Kim ST, Maron SB, Dayyani F, Catenacci DVT, Lee J, Chao J.

Oncologist. 2019 Jun 27. pii: theoncologist.2019-0121. doi: 10.1634/theoncologist.2019-0121. [Epub ahead of print]

PMID:
31249137
4.

Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors.

Chung JH, Dewal N, Sokol E, Mathew P, Whitehead R, Millis SZ, Frampton GM, Bratslavsky G, Pal SK, Lee RJ, Necchi A, Gregg JP, Lara P Jr, Antonarakis ES, Miller VA, Ross JS, Ali SM, Agarwal N.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.18.00283. Epub 2019 May 10.

5.

Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss.

Hyde PN, Sapper TN, Crabtree CD, LaFountain RA, Bowling ML, Buga A, Fell B, McSwiney FT, Dickerson RM, Miller VJ, Scandling D, Simonetti OP, Phinney SD, Kraemer WJ, King SA, Krauss RM, Volek JS.

JCI Insight. 2019 Jun 20;4(12). pii: 128308. doi: 10.1172/jci.insight.128308. eCollection 2019 Jun 20.

6.

Embryonic and larval development of the northern pike: An emerging fish model system for evo-devo research.

Pospisilova A, Brejcha J, Miller V, Holcman R, Šanda R, Stundl J.

J Morphol. 2019 Aug;280(8):1118-1140. doi: 10.1002/jmor.21005. Epub 2019 Jun 12.

PMID:
31188506
7.

Efficacy of Goniotomy with Kahook Dual Blade in Patients with Uveitis-associated Ocular Hypertension.

Miller VJ, Young CEC, SooHoo JR, Seibold LK, Kahook MY, Pecen PE, Palestine AG, Pantcheva MB.

J Glaucoma. 2019 Jun 10. doi: 10.1097/IJG.0000000000001298. [Epub ahead of print]

PMID:
31188228
8.

Vocabulary and Main Idea Reading Intervention Using Text Choice to Improve Content Knowledge and Reading Comprehension of Adolescents With Autism Spectrum Disorder.

Solis M, Reutebuch CK, Falcomata T, Steinle PK, Miller VL, Vaughn S.

Behav Modif. 2019 Jun 10:145445519853781. doi: 10.1177/0145445519853781. [Epub ahead of print]

PMID:
31177808
9.

Effects of animal protein supplementation of mothers, preterm infants, and term infants on growth outcomes in childhood: a systematic review and meta-analysis of randomized trials.

Pimpin L, Kranz S, Liu E, Shulkin M, Karageorgou D, Miller V, Fawzi W, Duggan C, Webb P, Mozaffarian D.

Am J Clin Nutr. 2019 Jun 8. pii: nqy348. doi: 10.1093/ajcn/nqy348. [Epub ahead of print]

PMID:
31175810
10.

Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors.

Necchi A, Bratslavsky G, Shapiro O, Elvin JA, Vergilio JA, Killian JK, Ngo N, Ramkissoon S, Severson E, Hemmerich AC, Ali SM, Chung JH, Reddy P, Miller VA, Schrock AB, Gay LM, Ross JS, Jacob JM.

Eur Urol Focus. 2019 May 27. pii: S2405-4569(19)30149-X. doi: 10.1016/j.euf.2019.05.012. [Epub ahead of print]

PMID:
31147264
11.

Temperature control of psaA expression by PsaE and PsaF in Y. pestis.

Quinn JD, Weening EH, Miner TA, Miller VL.

J Bacteriol. 2019 May 28. pii: JB.00217-19. doi: 10.1128/JB.00217-19. [Epub ahead of print]

13.

Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.

Parikh AR, He Y, Hong TS, Corcoran RB, Clark JW, Ryan DP, Zou L, Ting DT, Catenacci DV, Chao J, Fakih M, Klempner SJ, Ross JS, Frampton GM, Miller VA, Ali SM, Schrock AB.

Oncologist. 2019 Apr 30. pii: theoncologist.2019-0034. doi: 10.1634/theoncologist.2019-0034. [Epub ahead of print]

PMID:
31040255
14.

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.

Schrock AB, Ouyang C, Sandhu J, Sokol E, Jin D, Ross JS, Miller VA, Lim D, Amanam I, Chao J, Catenacci D, Cho M, Braiteh F, Klempner SJ, Ali SM, Fakih M.

Ann Oncol. 2019 Apr 30. pii: mdz134. doi: 10.1093/annonc/mdz134. [Epub ahead of print]

PMID:
31038663
15.

Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations from the Liver Forum.

Cheung A, Neuschwander-Tetri BA, Kleiner DE, Schabel E, Rinella M, Harrison S, Ratziu V, Sanyal AJ, Loomba R, Jeannin Megnien S, Torstenson R, Miller V; Liver Forum Case Definitions Working Group.

Hepatology. 2019 Apr 29. doi: 10.1002/hep.30672. [Epub ahead of print]

PMID:
31034092
16.

Changes Over Time in Good-Parent Beliefs Among Parents of Children With Serious Illness: A Two-Year Cohort Study.

Hill DL, Faerber JA, Li Y, Miller VA, Carroll KW, Morrison W, Hinds PS, Feudtner C.

J Pain Symptom Manage. 2019 Apr 23. pii: S0885-3924(19)30195-2. doi: 10.1016/j.jpainsymman.2019.04.018. [Epub ahead of print]

PMID:
31026508
17.

Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study.

Sicklick JK, Kato S, Okamura R, Schwaederle M, Hahn ME, Williams CB, De P, Krie A, Piccioni DE, Miller VA, Ross JS, Benson A, Webster J, Stephens PJ, Lee JJ, Fanta PT, Lippman SM, Leyland-Jones B, Kurzrock R.

Nat Med. 2019 May;25(5):744-750. doi: 10.1038/s41591-019-0407-5. Epub 2019 Apr 22.

PMID:
31011206
18.

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.

Rodon J, Soria JC, Berger R, Miller WH, Rubin E, Kugel A, Tsimberidou A, Saintigny P, Ackerstein A, Braña I, Loriot Y, Afshar M, Miller V, Wunder F, Bresson C, Martini JF, Raynaud J, Mendelsohn J, Batist G, Onn A, Tabernero J, Schilsky RL, Lazar V, Lee JJ, Kurzrock R.

Nat Med. 2019 May;25(5):751-758. doi: 10.1038/s41591-019-0424-4. Epub 2019 Apr 22.

PMID:
31011205
19.

Chronic Kidney Disease and Older African American Adults: How Embodiment Influences Self-Management.

Hamler TC, Miller VJ, Petrakovitz S.

Geriatrics (Basel). 2018 Aug 16;3(3). pii: E52. doi: 10.3390/geriatrics3030052. Review.

20.

Interprofessional Team Member Communication Patterns, Teamwork, and Collaboration in Pre-family Meeting Huddles in a Pediatric Cardiac Intensive Care Unit.

Walter JK, Schall TE, DeWitt AG, Faerber J, Griffis H, Galligan M, Miller V, Arnold RM, Feudtner C.

J Pain Symptom Manage. 2019 Jul;58(1):11-18. doi: 10.1016/j.jpainsymman.2019.04.009. Epub 2019 Apr 18.

PMID:
31004773
21.

Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness.

Goodman AM, Kato S, Chattopadhyay R, Okamura R, Saunders IM, Montesion M, Frampton GM, Miller VA, Daniels GA, Kurzrock R.

Cancer Immunol Res. 2019 Jun;7(6):866-873. doi: 10.1158/2326-6066.CIR-18-0716. Epub 2019 Apr 19.

PMID:
31003990
22.

The Evidence on Estrogen, Progesterone, and Spontaneous Coronary Artery Dissection.

Tweet MS, Miller VM, Hayes SN.

JAMA Cardiol. 2019 Apr 10. doi: 10.1001/jamacardio.2019.0774. [Epub ahead of print] No abstract available.

PMID:
30969320
23.

Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.

Singal G, Miller PG, Agarwala V, Li G, Kaushik G, Backenroth D, Gossai A, Frampton GM, Torres AZ, Lehnert EM, Bourque D, O'Connell C, Bowser B, Caron T, Baydur E, Seidl-Rathkopf K, Ivanov I, Alpha-Cobb G, Guria A, He J, Frank S, Nunnally AC, Bailey M, Jaskiw A, Feuchtbaum D, Nussbaum N, Abernethy AP, Miller VA.

JAMA. 2019 Apr 9;321(14):1391-1399. doi: 10.1001/jama.2019.3241.

PMID:
30964529
24.

The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned?

Miller VM, Naftolin F, Asthana S, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Gleason CE, Hodis HN, Jayachandran M, Kantarci K, Lobo RA, Manson JE, Pal L, Santoro NF, Taylor HS, Harman SM.

Menopause. 2019 Apr 1. doi: 10.1097/GME.0000000000001326. [Epub ahead of print]

PMID:
30939537
25.

Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers.

Drilon A, Schoenfeld AJ, Arbour KC, Litvak A, Ni A, Montecalvo J, Yu HA, Panora E, Ahn L, Kennedy M, Haughney-Siller A, Miller V, Ginsberg M, Ladanyi M, Arcila M, Rekhtman N, Kris MG, Riely GJ.

Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). pii: a003665. doi: 10.1101/mcs.a003665. Print 2019 Apr.

26.

A value-critical policy analysis of the nursing home reform act: a focus on care of African American and Latino residents.

Miller VJ, Hamler T.

Soc Work Health Care. 2019 May-Jun;58(5):471-493. doi: 10.1080/00981389.2019.1587660. Epub 2019 Mar 28.

PMID:
30920360
27.

A Klebsiella pneumoniae Regulatory Mutant Has Reduced Capsule Expression but Retains Hypermucoviscosity.

Walker KA, Miner TA, Palacios M, Trzilova D, Frederick DR, Broberg CA, Sepúlveda VE, Quinn JD, Miller VL.

MBio. 2019 Mar 26;10(2). pii: e00089-19. doi: 10.1128/mBio.00089-19.

28.

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.

Julg B, Dee L, Ananworanich J, Barouch DH, Bar K, Caskey M, Colby DJ, Dawson L, Dong KL, Dubé K, Eron J, Frater J, Gandhi RT, Geleziunas R, Goulder P, Hanna GJ, Jefferys R, Johnston R, Kuritzkes D, Li JZ, Likhitwonnawut U, van Lunzen J, Martinez-Picado J, Miller V, Montaner LJ, Nixon DF, Palm D, Pantaleo G, Peay H, Persaud D, Salzwedel J, Salzwedel K, Schacker T, Sheikh V, Søgaard OS, Spudich S, Stephenson K, Sugarman J, Taylor J, Tebas P, Tiemessen CT, Tressler R, Weiss CD, Zheng L, Robb ML, Michael NL, Mellors JW, Deeks SG, Walker BD.

Lancet HIV. 2019 Apr;6(4):e259-e268. doi: 10.1016/S2352-3018(19)30052-9. Epub 2019 Mar 15. Review.

PMID:
30885693
29.

Extended Ketogenic Diet and Physical Training Intervention in Military Personnel.

LaFountain RA, Miller VJ, Barnhart EC, Hyde PN, Crabtree CD, McSwiney FT, Beeler MK, Buga A, Sapper TN, Short JA, Bowling ML, Kraemer WJ, Simonetti OP, Maresh CM, Volek JS.

Mil Med. 2019 Mar 16. pii: usz046. doi: 10.1093/milmed/usz046. [Epub ahead of print]

PMID:
30877806
30.

Interprofessional Teamwork During Family Meetings in the Pediatric Cardiac Intensive Care Unit.

Walter JK, Sachs E, Schall TE, Dewitt AG, Miller VA, Arnold RM, Feudtner C.

J Pain Symptom Manage. 2019 Jun;57(6):1089-1098. doi: 10.1016/j.jpainsymman.2019.03.002. Epub 2019 Mar 12.

PMID:
30876957
31.

The Evolution of SlyA/RovA Transcription Factors from Repressors to Countersilencers in Enterobacteriaceae.

Will WR, Brzovic P, Le Trong I, Stenkamp RE, Lawrenz MB, Karlinsey JE, Navarre WW, Main-Hester K, Miller VL, Libby SJ, Fang FC.

MBio. 2019 Mar 5;10(2). pii: e00009-19. doi: 10.1128/mBio.00009-19.

32.

Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.

Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T, Brand RE, Zureikat AH, Roy S, Schrock AB, Miller VA, Ross JS, Ali SM, Bahary N.

Gastroenterology. 2019 Jun;156(8):2242-2253.e4. doi: 10.1053/j.gastro.2019.02.037. Epub 2019 Mar 2.

33.

Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature.

Bots SH, Groepenhoff F, Eikendal ALM, Tannenbaum C, Rochon PA, Regitz-Zagrosek V, Miller VM, Day D, Asselbergs FW, den Ruijter HM.

JACC Heart Fail. 2019 Mar;7(3):258-266. doi: 10.1016/j.jchf.2019.01.009.

34.

Toughening stretchable fibers via serial fracturing of a metallic core.

Cooper CB, Joshipura ID, Parekh DP, Norkett J, Mailen R, Miller VM, Genzer J, Dickey MD.

Sci Adv. 2019 Feb 22;5(2):eaat4600. doi: 10.1126/sciadv.aat4600. eCollection 2019 Feb.

35.

Dynamic formation of stable current-driven plasma jets.

Underwood TC, Loebner KTK, Miller VA, Cappelli MA.

Sci Rep. 2019 Feb 22;9(1):2588. doi: 10.1038/s41598-019-39827-6.

36.

On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation.

Brown BP, Zhang YK, Westover D, Yan Y, Qiao H, Huang V, Du Z, Smith JA, Ross JS, Miller VA, Ali S, Bazhenova L, Schrock AB, Meiler J, Lovly CM.

Clin Cancer Res. 2019 Jun 1;25(11):3341-3351. doi: 10.1158/1078-0432.CCR-18-3829. Epub 2019 Feb 22.

PMID:
30796031
37.

Correction: RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.

Loi S, Dushyanthen S, Beavis PA, Salgado R, Denkert C, Savas P, Combs S, Rimm DL, Giltnane JM, Estrada MV, Sánchez V, Sanders ME, Cook RS, Pilkinton MA, Mallal SA, Wang K, Miller VA, Stephens PJ, Yelensky R, Doimi FD, Gómez H, Ryzhov SV, Darcy PK, Arteaga CL, Balko JM.

Clin Cancer Res. 2019 Feb 15;25(4):1437. doi: 10.1158/1078-0432.CCR-18-4264. No abstract available.

PMID:
30770496
38.

Correction: PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors.

Croessmann S, Sheehan JH, Lee KM, Sliwoski G, He J, Nagy R, Riddle D, Mayer IA, Balko JM, Lanman R, Miller VA, Cantley LC, Meiler J, Arteaga CL.

Clin Cancer Res. 2019 Feb 15;25(4):1432. doi: 10.1158/1078-0432.CCR-18-4269. No abstract available.

PMID:
30770491
39.

Correction: An Acquired HER2 T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer.

Hanker AB, Brewer MR, Sheehan JH, Koch JP, Sliwoski GR, Nagy R, Lanman R, Berger MF, Hyman DM, Solit DB, He J, Miller V, Cutler RE Jr, Lalani AS, Cross D, Lovly CM, Meiler J, Arteaga CL.

Cancer Discov. 2019 Feb;9(2):303. doi: 10.1158/2159-8290.CD-18-1515. No abstract available.

PMID:
30737217
40.

Caregiver Burden and Desire for Institutional Placement-The Roles of Positive Aspects of Caregiving and Religious Coping.

Fields NL, Xu L, Miller VJ.

Am J Alzheimers Dis Other Demen. 2019 May;34(3):199-207. doi: 10.1177/1533317519826217. Epub 2019 Jan 30.

PMID:
30700106
41.

Attitudes of clinicians toward cardiac surgery and trisomy 18.

Kaulfus ME, Gardiner H, Hashmi SS, Mendez-Figueroa H, Miller VJ, Stevens B, Carter R.

J Genet Couns. 2019 Jun;28(3):654-663. doi: 10.1002/jgc4.1089. Epub 2019 Jan 28.

PMID:
30688390
42.

Hybrid Capture-Based Genomic Profiling Identifies BRAF V600 and Non-V600 Alterations in Melanoma Samples Negative by Prior Testing.

Boussemart L, Nelson A, Wong M, Ross JS, Sosman J, Mehnert J, Daniels G, Kendra K, Ali SM, Miller VA, Schrock AB.

Oncologist. 2019 May;24(5):657-663. doi: 10.1634/theoncologist.2018-0271. Epub 2019 Jan 25.

PMID:
30683711
43.

Variable Response to ALK Inhibitors in NSCLC with a Novel MYT1L-ALK Fusion.

Tsou TC, Gowen K, Ali SM, Miller VA, Schrock AB, Lovly CM, Reckamp KL.

J Thorac Oncol. 2019 Feb;14(2):e29-e30. doi: 10.1016/j.jtho.2018.10.169. No abstract available.

PMID:
30683295
44.

Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.

Pramar YV, Mandal TK, Bostanian LA, Nguyen AT, Miller V, Morris TC, Graves RA.

Int J Pharm Compd. 2019 Jan-Feb;23(1):70-76.

PMID:
30668538
45.

Cerebrovascular reactivity after cessation of menopausal hormone treatment.

Barnes JN, Harvey RE, Eisenmann NA, Miller KB, Johnson MC, Kruse SM, Lahr BD, Joyner MJ, Miller VM.

Climacteric. 2019 Apr;22(2):182-189. doi: 10.1080/13697137.2018.1538340. Epub 2019 Jan 21.

PMID:
30661405
46.

The Role of Cognitive and Psychosocial Maturity in Type 1 Diabetes Management.

Silva K, Miller VA.

J Adolesc Health. 2019 May;64(5):622-630. doi: 10.1016/j.jadohealth.2018.10.294. Epub 2019 Jan 14.

PMID:
30655120
47.

Caregiver identity theory and predictors of burden and depression: Findings from the REACH II study.

Miller VJ, Killian MO, Fields N.

Aging Ment Health. 2018 Dec 27:1-9. doi: 10.1080/13607863.2018.1533522. [Epub ahead of print]

PMID:
30588825
48.

Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.

Galanina N, Bejar R, Choi M, Goodman A, Wieduwilt M, Mulroney C, Kim L, Yeerna H, Tamayo P, Vergilio JA, Mughal TI, Miller V, Jamieson C, Kurzrock R.

Cancers (Basel). 2018 Dec 21;11(1). pii: E11. doi: 10.3390/cancers11010011.

49.

Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.

Millis SZ, Jardim DL, Albacker L, Ross JS, Miller VA, Ali SM, Kurzrock R.

Cancer. 2019 Apr 1;125(7):1185-1199. doi: 10.1002/cncr.31921. Epub 2018 Dec 24.

50.

Tumor mutational burden and response to programmed cell death protein 1 inhibitors in a case series of patients with metastatic desmoplastic melanoma.

Boussemart L, Johnson A, Schrock AB, Pal SK, Frampton GM, Fabrizio D, Chalmers Z, Lotem M, Gibney G, Russell J, Chmielowski B, Ross JS, Stephens PJ, Miller VA, Ali SM.

J Am Acad Dermatol. 2019 Jun;80(6):1780-1782. doi: 10.1016/j.jaad.2018.12.020. Epub 2018 Dec 18. No abstract available.

Supplemental Content

Loading ...
Support Center